Stopping the primal RAGE reaction in myocardial infarction: capturing adaptive responses to heal the heart?
Stopping the primal RAGE reaction in myocardial infarction: capturing adaptive responses to heal the heart?
复制标题
停止心肌梗塞中的原始 RAGE 反应：捕捉适应性反应来治愈心脏？
DOI：
10.1161/circulationaha.108.784397
复制
发表时间：
2008
期刊：
影响因子：
37.8
通讯作者：
Schmidt,AnnMarie
中科院分区：
文献类型：
--
作者：
Ramasamy,Ravichandran;Yan,ShiFang;Schmidt,AnnMarie
The report of Andrassy and colleagues1 in the current issue of Circulation adds to the growing body of evidence that the receptor for advanced glycation end products (RAGE) and its ligands, particularly high mobility group box-1 (HMGB1), are central mediators of ischemia/reperfusion (I/R) injury in the heart. 1–4 A major cause of injury, especially in the reperfusion phase, is the influx of inflammatory cells into the stressed heart. Andrassy and colleagues show that infiltrating leukocytes express proinflammatory HMGB1 and that HMGB1 plays fundamental roles in injury responses in the I/R heart. In homeostasis, HMGB1 is largely a nuclear protein. In stress conditions, HMGB1 may be released from injured cells, particularly on necrosis. The chief receptor for HMGB1, RAGE, is expressed in multiple cell types in the I/R heart, such as inflammatory cells, and also in cardiomyocytes and vascular cells (endothelial cells and smooth muscle cells). 2 Although HMGB1 may interact with distinct receptors beyond RAGE (for example, toll receptors), 5 the current study of Andrassy and colleagues reveals major roles for RAGE in transducing the effects of HMGB1 in the heart, as administration of recombinant HMGB1 or antagonists of this molecule had significant proinjury effects in the wild-type mouse heart, but no additive effects were noted in mice devoid of RAGE. The biology of RAGE, however, is complex and extends beyond HMGB1 in the injured heart.
